Loading...
Loading...
Browse all stories on DeepNewz
VisitBMA to publicly endorse Cass Review on pediatric gender transition treatment by end of 2024?
Yes • 50%
No • 50%
Official statements or publications from the British Medical Association (BMA)
BMA to Evaluate Cass Review on Pediatric Gender Transition Treatment, Despite High Court Endorsement
Jul 31, 2024, 03:44 PM
The British Medical Association (BMA) has announced it will undertake an evaluation of the Cass Review, which found that pediatric gender transition treatment is based on 'remarkably weak evidence.' This decision follows a recent vote by the BMA's Council in favor of a motion to publicly critique the review. The announcement comes shortly after the High Court described the Cass Review as 'the best and most up to date scientific evidence available.' Additionally, the High Court ruled that ministers have the right under the 1968 Medicines Act to make decisions based on the Cass Review. The BMA's move has sparked significant debate within the medical community.
View original story
Support the ban • 25%
Oppose the ban • 25%
Call for more research • 25%
Remain neutral • 25%
Guidelines announced • 25%
No change in guidelines • 25%
Guidelines under review • 25%
Other • 25%
Yes • 50%
No • 50%
Support the ruling • 25%
Oppose the ruling • 25%
Neutral stance • 25%
Other • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No official stance • 25%
Endorse the Cass Review • 25%
Critique the Cass Review • 25%
Request further research • 25%
Mostly positive • 25%
Indifferent • 25%
Mixed reactions • 25%
Mostly negative • 25%